donepezil has been researched along with pf9601n in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agbaba, D; Alcaro, S; Bautista-Aguilera, OM; Chioua, M; de Andrés, L; Filipic, S; Marco-Contelles, J; Nikolic, K; Ortuso, F; Ramsay, RR; Rodríguez-Franco, MI; Samadi, A; Soriano, E; Yañez, M | 1 |
1 other study(ies) available for donepezil and pf9601n
Article | Year |
---|---|
N-Methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor.
Topics: Animals; Blood-Brain Barrier; Brain; Cell Membrane Permeability; Cholinesterase Inhibitors; Cholinesterases; Indoles; Models, Molecular; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Swine | 2014 |